...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: A lesson on futility analyses from the CETP inhibitors
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Just a clarification, there are 3 CETP programs still alive. Merck's anacetrapib/REVEAL study as presented earlier, dalcetrapib in a Phase 3 trial in a genetically defined population, and Amgen's AMG-899 (formerly Dezima's TA-8995) which passed Phase 2 and yet to start Phase 3. 

4 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply